West Nile Virus: a Reemerging Global Pathogen
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Flavivirus: from Structure to Therapeutics Development
life Review Flavivirus: From Structure to Therapeutics Development Rong Zhao 1,2,†, Meiyue Wang 1,2,†, Jing Cao 1,2, Jing Shen 1,2, Xin Zhou 3, Deping Wang 1,2,* and Jimin Cao 1,2,* 1 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China; [email protected] (R.Z.); [email protected] (M.W.); [email protected] (J.C.); [email protected] (J.S.) 2 Department of Physiology, Shanxi Medical University, Taiyuan 030001, China 3 Department of Medical Imaging, Shanxi Medical University, Taiyuan 030001, China; [email protected] * Correspondence: [email protected] (D.W.); [email protected] (J.C.) † These authors contributed equally to this work. Abstract: Flaviviruses are still a hidden threat to global human safety, as we are reminded by recent reports of dengue virus infections in Singapore and African-lineage-like Zika virus infections in Brazil. Therapeutic drugs or vaccines for flavivirus infections are in urgent need but are not well developed. The Flaviviridae family comprises a large group of enveloped viruses with a single-strand RNA genome of positive polarity. The genome of flavivirus encodes ten proteins, and each of them plays a different and important role in viral infection. In this review, we briefly summarized the major information of flavivirus and further introduced some strategies for the design and development of vaccines and anti-flavivirus compound drugs based on the structure of the viral proteins. There is no doubt that in the past few years, studies of antiviral drugs have achieved solid progress based on better understanding of the flavivirus biology. -
Dengue Fever and Dengue Hemorrhagic Fever (Dhf)
DENGUE FEVER AND DENGUE HEMORRHAGIC FEVER (DHF) What are DENGUE and DHF? Dengue and DHF are viral diseases transmitted by mosquitoes in tropical and subtropical regions of the world. Cases of dengue and DHF are confirmed every year in travelers returning to the United States after visits to regions such as the South Pacific, Asia, the Caribbean, the Americas and Africa. How is dengue fever spread? Dengue virus is transmitted to people by the bite of an infected mosquito. Dengue cannot be spread directly from person to person. What are the symptoms of dengue fever? The most common symptoms of dengue are high fever for 2–7 days, severe headache, backache, joint pains, nausea and vomiting, eye pain and rash. The rash is frequently not visible in dark-skinned people. Young children typically have a milder illness than older children and adults. Most patients report a non-specific flu-like illness. Many patients infected with dengue will not show any symptoms. DHF is a more severe form of dengue. Initial symptoms are the same as dengue but are followed by bleeding problems such as easy bruising, skin hemorrhages, bleeding from the nose or gums, and possible bleeding of the internal organs. DHF is very rare. How soon after exposure do symptoms appear? Symptoms of dengue can occur from 3-14 days, commonly 4-7 days, after the bite of an infected mosquito. What is the treatment for dengue fever? There is no specific treatment for dengue. Treatment usually involves treating symptoms such as managing fever, general aches and pains. Persons who have traveled to a tropical or sub-tropical region should consult their physician if they develop symptoms. -
Efficacy of Vaccines in Animal Models of Ebolavirus Disease
Supplemental Table 1. Efficacy of vaccines in animal models of Ebolavirus disease. Vaccines Immunization Schedule Mouse Model Guinea Pig Model NHP Model Virus Vectors HPIV3 Immunogens Guinea Pigs: Complete protection Complete protection HPIV3 ∆HN-F/ EBOV GP IN 4 x 106 PFU of HPIV3 with HPIV3 ∆HN-F/EBOV with 2 doses of [1] ∆HN-F/EBOV GP or GP, HPIV3/EBOV GP, or HPIV3/EBOV GP [3] EBOV GP [1-3] HPIV3/EBOV GP [1] HPIV3/EBOV NP [1, 2] No advantage to EBOV NP [2] IN 105.3 PFU of HPIV/EBOV Strong humoral response bivalent vaccines EBOV GP + NP [3] GP or NP [2] EBOV GP +GM-CSF [3] HPIV3- NHPs: 6 IN plus IT 4 x 10 TCID50 of HPIV3/EBOV GP, HPIV3/EBOV GP+GM-CSF, HPIV3/EBOVGP NP or 2 x 7 10 TCID50 of HPIV3/EBOV GP for 1–2 doses [3] RABV ∆GP/EBOV GP Mice: IM 5 x 105 FFU Complete protection with (Live attenuated) [4] either vector RABV/EBOV GP fused to EBOV GP incorporation into GCD of RABV virions not dependent on (inactivated) [4] RABV GCD Human Ad5 Immunogens Mice: With induced preexisting Ad5 With systemically CMVEBOV GP [5-9] IN, PO, IM 1 x 1010 [6] to 5 immunity, complete induced preexisting Ad5 CAGoptEBOV GP [8, 9] x 1010 [5] particles of protection with only IN immunity, complete Ad5/CMVEBOV GP Ad5/CMVEBOV GP [5] protection with IN IP 1 x 108 PFU With no Ad5 immunity: Ad5/CMVEBOV GP [8] Ad5/CMVEBOV GP[7] complete protection With mucosally induced IM 1 x 104–1 x 107 IFU of regardless of route [5-7, 9] preexisting Ad5 Ad5/CMVEBOV GP or 1 x Mucosal immunization Ad5- immunity, 83% 104–1 x 106 IFU of EBOV GP increased cellular -
Wnv-Case-Definition.Pdf
Draft Case Definition for West Nile Fever Animal and Plant Health Inspection Service West Nile Fever Veterinary Services October 2018 Case Definition (Notifiable) 1. Clinical Signs 1.1 Clinical Signs: West Nile Fever (WNF) is a zoonotic mosquito-borne viral disease caused by the West Nile virus (WNV), a Flavivirus of the family Flaviviridae. Many vertebrate species are susceptible to natural WNV infection; however, fatal neurological outbreaks have only been documented in equids, humans, geese, wild birds (particularly corvids), squirrels, farmed alligators, and dogs. Birds serve as the natural host reservoir of WNV. The incubation period is estimated to be three to 15 days in horses Ten to 39 percent of unvaccinated horses infected with WNV will develop clinical signs. Most clinically affected horses exhibit neurological signs such as ataxia (including stumbling, staggering, wobbly gait, or incoordination) or at least two of the following: circling, hind limb weakness, recumbency or inability to stand (or both), multiple limb paralysis, muscle fasciculation, proprioceptive deficits, altered mental status, blindness, lip droop/paralysis, teeth grinding. Behavioral changes including somnolence, listlessness, apprehension, or periods of hyperexcitability may occur. Other common clinical signs include colic, lameness, anorexia, and fever. 2. Laboratory criteria: 2.1 Agent isolation and identification: The virus can be identified by polymerase chain reaction (PCR) and virus isolation (VI). Preferred tissues from equids are brain or spinal cord. 2.2 Serology: Antibody titers can be identified in paired serum samples by IgM and IgG capture enzyme linked immunosorbent assay (ELISA), plaque reduction neutralization test (PRNT), and virus neutralization (VN). Only a single serum sample is required for IgM capture ELISA, and this is the preferred serologic test in live animals. -
Dengue and Yellow Fever
GBL42 11/27/03 4:02 PM Page 262 CHAPTER 42 Dengue and Yellow Fever Dengue, 262 Yellow fever, 265 Further reading, 266 While the most important viral haemorrhagic tor (Aedes aegypti) as well as reinfestation of this fevers numerically (dengue and yellow fever) are insect into Central and South America (it was transmitted exclusively by arthropods, other largely eradicated in the 1960s). Other factors arboviral haemorrhagic fevers (Crimean– include intercontinental transport of car tyres Congo and Rift Valley fevers) can also be trans- containing Aedes albopictus eggs, overcrowding mitted directly by body fluids. A third group of of refugee and urban populations and increasing haemorrhagic fever viruses (Lassa, Ebola, Mar- human travel. In hyperendemic areas of Asia, burg) are only transmitted directly, and are not disease is seen mainly in children. transmitted by arthropods at all. The directly Aedes mosquitoes are ‘peri-domestic’: they transmissible viral haemorrhagic fevers are dis- breed in collections of fresh water around the cussed in Chapter 41. house (e.g. water storage jars).They feed on hu- mans (anthrophilic), mainly by day, and feed re- peatedly on different hosts (enhancing their role Dengue as vectors). Dengue virus is numerically the most important Clinical features arbovirus infecting humans, with an estimated Dengue virus may cause a non-specific febrile 100 million cases per year and 2.5 billion people illness or asymptomatic infection, especially in at risk.There are four serotypes of dengue virus, young children. However, there are two main transmitted by Aedes mosquitoes, and it is un- clinical dengue syndromes: dengue fever (DF) usual among arboviruses in that humans are the and dengue haemorrhagic fever (DHF). -
First Detection of the West Nile Virus Koutango Lineage in Sandflies In
pathogens Article First Detection of the West Nile Virus Koutango Lineage in Sandflies in Niger Gamou Fall 1,* , Diawo Diallo 2 , Hadiza Soumaila 3,4, El Hadji Ndiaye 2 , Adamou Lagare 5, Bacary Djilocalisse Sadio 1, Marie Henriette Dior Ndione 1, Michael Wiley 6,7 , Moussa Dia 1, Mamadou Diop 8, Arame Ba 1, Fati Sidikou 5, Bienvenu Baruani Ngoy 9, Oumar Faye 1, Jean Testa 5, Cheikh Loucoubar 8 , Amadou Alpha Sall 1, Mawlouth Diallo 2 and Ousmane Faye 1 1 Pole of Virology, WHO Collaborating Center For Arbovirus and Haemorrhagic Fever Virus, Institut Pasteur, Dakar BP 220, Senegal; [email protected] (B.D.S.); [email protected] (M.H.D.N.); [email protected] (M.D.); [email protected] (A.B.); [email protected] (O.F.); [email protected] (A.A.S.); [email protected] (O.F.) 2 Citation: Fall, G.; Diallo, D.; Pole of Zoology, Medical Entomology Unit, Institut Pasteur, Dakar BP 220, Senegal; Soumaila, H.; Ndiaye, E.H.; Lagare, [email protected] (D.D.); [email protected] (E.H.N.); [email protected] (M.D.) 3 A.; Sadio, B.D.; Ndione, M.H.D.; Programme National de Lutte contre le Paludisme, Ministère de la Santé Publique du Niger, Niamey BP 623, Niger; [email protected] Wiley, M.; Dia, M.; Diop, M.; et al. 4 PMI Vector Link Project, Niamey BP 11051, Niger First Detection of the West Nile Virus 5 Centre de Recherche Médicale et Sanitaire, Niamey BP 10887, Niger; [email protected] (A.L.); Koutango Lineage in Sandflies in [email protected] (F.S.); [email protected] (J.T.) Niger. -
Florida Arbovirus Surveillance Week 13: March 28-April 3, 2021
Florida Arbovirus Surveillance Week 13: March 28-April 3, 2021 Arbovirus surveillance in Florida includes endemic mosquito-borne viruses such as West Nile virus (WNV), Eastern equine encephalitis virus (EEEV), and St. Louis encephalitis virus (SLEV), as well as exotic viruses such as dengue virus (DENV), chikungunya virus (CHIKV), Zika virus (ZIKV), and California encephalitis group viruses (CEV). Malaria, a parasitic mosquito-borne disease is also included. During the period of March 28- April 3, 2021, the following arboviral activity was recorded in Florida. WNV activity: No human cases of WNV infection were reported this week. No horses with WNV infection were reported this week. No sentinel chickens tested positive for antibodies to WNV this week. In 2021, positive samples from two sentinel chickens has been reported from two counties. SLEV activity: No human cases of SLEV infection were reported this week. No sentinel chickens tested positive for antibodies to SLEV this week. In 2021, no positive samples have been reported. EEEV activity: No human cases of EEEV infection were reported this week. No horses with EEEV infection were reported this week. No sentinel chickens tested positive for antibodies to EEEV this week. In 2021, positive samples from one horse and 14 sentinel chickens have been reported from four counties. International Travel-Associated Dengue Fever Cases: No cases of dengue fever were reported this week in persons that had international travel. In 2021, one travel-associated dengue fever case has been reported. Dengue Fever Cases Acquired in Florida: No cases of locally acquired dengue fever were reported this week. In 2021, no cases of locally acquired dengue fever have been reported. -
Rift Valley Fever for Host Innate Immunity in Resistance to a New
A New Mouse Model Reveals a Critical Role for Host Innate Immunity in Resistance to Rift Valley Fever This information is current as Tânia Zaverucha do Valle, Agnès Billecocq, Laurent of September 25, 2021. Guillemot, Rudi Alberts, Céline Gommet, Robert Geffers, Kátia Calabrese, Klaus Schughart, Michèle Bouloy, Xavier Montagutelli and Jean-Jacques Panthier J Immunol 2010; 185:6146-6156; Prepublished online 11 October 2010; Downloaded from doi: 10.4049/jimmunol.1000949 http://www.jimmunol.org/content/185/10/6146 Supplementary http://www.jimmunol.org/content/suppl/2010/10/12/jimmunol.100094 http://www.jimmunol.org/ Material 9.DC1 References This article cites 46 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/185/10/6146.full#ref-list-1 Why The JI? Submit online. by guest on September 25, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2010 by The American -
West Nile Virus Questions and Answers
West Nile Virus Questions and Answers Q: How do people get infected with West Nile Virus (WNV)? A: The most likely way a human would become infected with WNV is through the bite of an infected mosquito. Some people have also become infected with WNV following receipt of contaminated blood or blood products, or transplanted organs from an infected donor. Mothers who are recently infected with WNV may also transmit the virus to their unborn child, or to their baby while breastfeeding. Q: Who is at risk for getting West Nile encephalitis? A: All residents of areas where WNV activity has been identified are at risk of getting West Nile encephalitis. Q: What is the time from exposure to onset of disease symptoms for West Nile encephalitis in humans? A: Usually 3 to 15 days. Q: What are the symptoms of West Nile virus infection? A: Most people who are infected with WNV will not have any noticeable illness, or have a mild form of illness called West Nile Fever. Persons with West Nile Fever typically experience symptoms of fever, headache, nausea, muscle weakness, and body aches lasting 2 to 6 days or longer. Sensitivity when looking at light and a skin rash appearing on the trunk of the body may also be present. Approximately 20% of persons infected with WNV will develop more severe neurologic disease that may be life-threatening. Adults over the age of 50 years are at greater risk of having serious disease. Potential symptoms of severe infection (West Nile encephalitis or meningitis) include intense headache, dizziness, severe muscle weakness, neck stiffness, vomiting, disorientation, mental confusion, tremors, muscle paralysis, or convulsions and coma. -
Combatting Malaria, Dengue and Zika Using Nuclear Technology by Nicole Jawerth and Elodie Broussard
Infectious Diseases Combatting malaria, dengue and Zika using nuclear technology By Nicole Jawerth and Elodie Broussard A male Aedes species mosquito. iseases such as malaria, dengue and transcription–polymerase chain reaction (Photo: IAEA) Zika, spread by various mosquito (RT–PCR) (see page 8). Experts across the Dspecies, are wreaking havoc on millions of world have been trained and equipped by lives worldwide. To combat these harmful the IAEA to use this technique for detecting, and often life-threatening diseases, experts tracking and studying pathogens such as in many countries are turning to nuclear and viruses. The diagnostic results help health nuclear-derived techniques for both disease care professionals to provide treatment and detection and insect control. enable experts to track the viruses and take action to control their spread. Dengue and Zika When a new outbreak of disease struck in The dengue virus and Zika virus are mainly 2015 and 2016, physicians weren’t sure of spread by Aedes species mosquitoes, which its cause, but RT–PCR helped to determine are most common in tropical regions. In most that the outbreak was the Zika virus and not cases, the dengue virus causes debilitating another virus such as dengue. RT–PCR was flu-like symptoms, but all four strains of the used to detect the virus in infected people virus also have the potential to cause severe, throughout the epidemic, which was declared life-threatening diseases. In the case of the Zika a public health emergency of international virus, many infected people are asymptomatic concern by the World Health Organization or only have mild symptoms; however, the virus (WHO) in January 2016. -
Dengue Fever (Breakbone Fever, Dengue Hemorrhagic Fever)
Division of Disease Control What Do I Need to Know? Dengue Fever (breakbone fever, dengue hemorrhagic fever) What is Dengue Fever? Dengue fever is a serious form of mosquito-borne disease caused one of four closely related viruses called Flaviviruses. They are named DENV 1, DENV 2, DENV 3, or DENV 4. The disease is found in most tropical and subtropical areas (including some islands in the Caribbean, Mexico, most countries of South and Central America, the Pacific, Asia, parts of tropical Africa and Australia). Almost all cases reported in the continental United States are in travelers who have recently returned from countries where the disease circulates. Dengue is endemic to the U.S. territories of Puerto Rico, the Virgin Islands, and Guam and in recent years non-travel related cases have been found in Texas, Florida, and Hawaii. Who is at risk for Dengue Fever? Dengue fever may occur in people of all ages who are exposed to infected mosquitoes. The disease occurs in areas where the mosquitos that carry dengue circulate, usually during the rainy seasons when mosquito populations are at high numbers. What are the symptoms of Dengue Fever? Dengue fever is characterized by the rapid development of fever that may last from two to seven days, intense headache, joint and muscle pain and a rash. The rash develops on the feet or legs three to four days after the beginning of the fever. Some people with dengue develop dengue hemorrhagic fever (DHF). Symptoms of DHF are characteristic of internal bleeding and include: severe abdominal pain, red patches on skin, bleeding from nose or gums, black stools, vomiting blood, drowsiness, cold and clammy skin and difficulty breathing. -
Prevent Dengue & Chikungunya
Prevent Dengue & Chikungunya WHO Myanmar newsletter special, 9 September 2019 What is dengue? Dengue situation in Myanmar Dengue is one of the most common mosquito- Cases and deaths 2015-2019 borne viral infections. The infection is spread from one person to another through the bite of infectious mosquitoes, either Aedes aegypti or Aedes albopictus. There are 4 distinct types of dengue virus, called DEN-1, DEN-2, DEN-3 and DEN-4. Dengue can be mild, as in most cases, or severe, as in few cases. It can cause serious illness and death among children. In Myanmar, July to August is peak season for transmission of dengue - coinciding with monsoon. How every one of us can help prevent dengue source: VBDC, Department of Public Health, Ministry of Health & Sports, 2019 z community awareness for mosquito breeding As shown above, dengue is cyclical in Myanmar, control is key alternating annually, as is the case in many countries. z cover, empty and clean domestic water storage At the same time, the number of dengue cases, and containers -- weekly is best deaths due to denge, over the period 2015 to 2018, z remove from the environment plastic bottles, both show a decreasing trend overall. plastic bags, fruit cans, discarded tyres -- for these are preferred mosquito breeding sites by Examples of how national and local authorities aedes aegypti (depicted) and aedes albopictus contribute z drain water collection points around the house z providing support for dengue management at z seek advice of a health professional if you have health facilities. multiple signs or symptoms of dengue z strengthening online reporting of dengue, How to recognize dengue? what are signs and using electronic based information system.